Emfogen 25 mg (Tablet)
Unit Price: ৳ 40.00 (1 x 10: ৳ 400.00)
Strip Price: ৳ 400.00
Medicine Details
Category | Details |
---|---|
Generic | Empagliflozin |
Company | General pharmaceuticals ltd |
Also available as |
Title
- Emfogen 25 mg Tablet
Categories
- Medicine
- SGLT2 Inhibitor
- Diabetes Management
Description
- Indicated in adults with type 2 diabetes mellitus
- Reduces the risk of cardiovascular death in adult patients with type 2 diabetes mellitus and established cardiovascular disease
- Sodium glucose co-transporter-2 (SGLT-2) inhibitor
- Recommended dose is 10 mg once daily, may be increased to 25 mg once daily
- Interacts with diuretics, insulin/insulin secretagogues
- Common adverse reactions include urinary tract infections and female genital mycotic infections
- Contraindicated in patients with serious hypersensitivity, severe renal impairment, end-stage renal disease, or dialysis
- Not well studied in pregnant women, not recommended during breastfeeding
- Assessment of renal function recommended prior to initiation
- Storage: Keep below 30°C, protected from light & moisture
Dimensions
- Standard Tablet Size
Color Options
- None
Functions
- Improves glycemic control
- Reduces renal absorption of glucose
- Lowers renal threshold for glucose
- Increases glucose excretion
- Assists weight loss
- Reduces blood pressure
Materials
- Chemical Compound: C23H27ClO7
Technical Specifications
- Molecular Formula: C23H27ClO7
Design Elements
- Chemical Structure Image
Usability Features
- Recommended dosage of 10 mg or 25 mg once daily
- Adjustable dosage based on tolerance
- Corrects volume depletion prior to initiation
- Multiple indications for use
- Interaction warnings with other medications
- Assessment and precautions for renal function
- Storage guidance for maintaining potency
Pregnancy & Lactation
- Potential benefit justifies potential risk to the fetus
- Not recommended during breastfeeding
Safety Features
- Contraindications for specific patient conditions
Overdose Effects
- Supportive measures recommended in case of overdose
Therapeutic Class
- Sodium-glucose Cotransporter-2 (SGLT2) Inhibitors
Storage Conditions
- Cool & dry place, protected from light & moisture
Chemical Structure
- Molecular Formula: C23H27ClO7
- Chemical Structure Image
Commonly Asked Questions
- Indications for use
- Safe usage during pregnancy and breastfeeding
- Impact on kidney and liver function
- Quick tips for responsible usage